Ravulizumab is a monoclonal antibody medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare blood disorder. It is a type of C5 complement inhibitor, which means it works by blocking the C5 protein in the complement system, which is part of the body's immune system. It is manufactured by the biotechnology company Alexion Pharmaceuticals. Ravulizumab is administered through intravenous infusion, typically on a monthly basis. It has been approved in the US, Europe, and other countries.
Ravulizumab, sold under the brand name Ultomiris, is a medication used to treat two specific rare blood disorders:
- Paroxysmal nocturnal hemoglobinuria (PNH): This is a life-threatening condition where red blood cells are abnormally broken down (hemolysis) by the immune system [1, 2].
- Atypical hemolytic uremic syndrome (aHUS): This is a serious blood clotting disorder that can damage the kidneys [3, 4].
Here's a closer look at how Ravulizumab works and its applications in these conditions:
Mechanism of Action:
- Ravulizumab belongs to a class of drugs called complement C5 complement inhibitors [1, 3]. The complement system is a part of the immune system involved in inflammatory responses.
- Ravulizumab specifically targets a protein called C5 in the complement pathway. By blocking C5, Ravulizumab helps prevent the uncontrolled activation of the complement system, which can damage red blood cells in PNH and blood vessels in aHUS [1, 3].
How it's Used:
- Ravulizumab is administered intravenously (through a vein) by a healthcare professional, typically at intervals of 4 or 8 weeks depending on the condition being treated [1, 3].
- It's usually used as a long-term treatment for PNH and aHUS [1, 3].
Benefits:
- In PNH, Ravulizumab can significantly reduce hemolysis, preventing red blood cell destruction and improving symptoms like fatigue and shortness of breath [1, 2].
- In aHUS, Ravulizumab helps control the abnormal activation of the complement system, preventing damage to the kidneys and other organs [3, 4].
Important Considerations:
- Ravulizumab is a powerful medication and may not be suitable for everyone. Your doctor will assess your individual situation and medical history before prescribing it [1, 3].
- Potential side effects include upper respiratory tract infections, headache, diarrhea, and back pain [1, 3].
- Regular monitoring by your doctor is necessary while receiving Ravulizumab, including blood tests to assess blood cell counts and kidney function [1, 3].